Polly Lama was supported by the Indian Council of Medical Research (ICMR), Grant number 5/7/1290/2015 RCH
This can aid in maintaining stable blood sugar levels and prolong feelings of fullness, controlling cravings and appetite
Bedin M, Ferre F, Alsat E, Cedard L (1980) Regulation of steroidogenesis in the human placenta

For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision

For most patients, the question isnt which format is most pharmacologically efficient. Its which format will I actually take, every week, for months? A patient who refuses to inject themselves and skips the injection altogether gets zero benefit from semaglutides higher bioavailability